Business Context and Reporting Period
Company: GlaxoSmithKline PLC
Date: November 1, 2002
Event: Share repurchase and cancellation authorized by shareholders at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It reports a specific capital transaction:
- Shares Purchased: 830,000 Ordinary 25 pence shares
- Price per Share: 1,200.98 pence
- Transaction Date: November 1, 2002
Material Changes
The filing does not provide comparative financial data or material changes in operating performance versus prior periods. The primary change is the reduction of outstanding share capital through the cancellation of 830,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, risk factors, contingencies, or unusual items beyond the execution of the authorized share buyback.
Investor Verification Points
- Confirm the total cost of the repurchase (830,000 shares x 1,200.98 pence).
- Verify the impact of this cancellation on the total number of outstanding shares.
- Check subsequent filings for the remaining authority under the May 20, 2002 shareholder mandate.